Santa Casa de Misericórdia de Passos
In research, Santa Casa de Misericórdia de Passos stands highest in Health Sciences (#17,602 of 20,462 worldwide) and Medicine (#15,847 of 17,978 worldwide), over all time.
- World rank, all time
- #37,883 of 42,892
- Rank in Brazil
- #714 of 870
- Research works
- 258 ▼ 16% vs 2013–17
- Citations
- 2.6k 10.2 per fractional work
- Top-10% rate
- 4.8% record average 16.5%
- Open access
- 72% world 28%
What is Santa Casa de Misericórdia de Passos known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #17,602 of 20,462 | 6.3% | 188 | |
| MedicineField | #15,847 of 17,978 | 5.8% | 167 |
Each strip is that field’s whole ranked pool, with the notch where Santa Casa de Misericórdia de Passos sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.6×. Every wedge is a field page.
- Immunology and Microbiology 3.6×
- Dentistry 3.4×
- Nursing 3.1×
- Health Professions 3.0×
- Medicine 3.0×
- Veterinary 1.6×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Decision Sciences 0.8×
- Social Sciences 0.7×
- Agricultural and Biological Sciences 0.5×
- Neuroscience 0.4×
- Business, Management and Accounting 0.4×
- Economics, Econometrics and Finance 0.3×
- Computer Science 0.3×
- Psychology 0.3×
- Environmental Science 0.3×
- Chemistry 0.2×
- Arts and Humanities 0.0×
- Engineering 0.0×
Which keywords describe research at Santa Casa de Misericórdia de Passos?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Public Health, Quality of Life, Diagnosis, Complications, Autoantibodies and Health Policy.
- Synthetic
- Disease-Modifying Antirheumatic Drugs
- Kidney Transplantation
- Apoptosis
- Surgery
- Public Policy
- Healthcare Regulation
- Alzheimer's Disease
- Radiotherapy
- Healthcare Access
- Drug Resistance
- Management
- Vasculitides
- Rheumatoid Arthritis
- Cancer
- Patient Safety
- Autoantibodies
- Educational Technology
- Quality of Life
- Public Health
- Epidemiology
- Treatment
- Diagnosis
- Complications
- Health Policy
- ANCA-associated
- Genetics
- Rituximab
- Healthcare
- Cardiovascular Risk
- Ethical Considerations
- Infection Control
- Transplantation
- Anatomy
- Medical Devices
- Smart Library
- Validity and Reliability
- Cytokines
- Biological Therapy
- Phosphoethanolamine
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 4.3×37 topics
- Public Health5▲ 6.3×9 topics
- Treatment4▲ 7.4×18 topics
- Quality of Life4▲ 5.0×16 topics
- Diagnosis3▲ 6.5×13 topics
- Educational Technology2▲ 3.6×3 topics
- Complications2▲ 8.3×9 topics
- Autoantibodies2▲ 17×6 topics
- Health Policy2▲ 23×2 topics
- Patient Safety2▲ 25×4 topics
- ANCA-associated2▲ 131×1 topic
- Cancer2▲ 2.6×7 topics
- Genetics2▲ 5.0×6 topics
- Rheumatoid Arthritis2▲ 35×2 topics
- Rituximab2▲ 23×3 topics
- Vasculitides2▲ 131×1 topic
- Healthcare2▲ 2.9×3 topics
- Management2▲ 3.9×11 topics
- Cardiovascular Risk1▲ 9.2×3 topics
- Drug Resistance1▲ 9.8×2 topics
- Ethical Considerations1▲ 8.1×3 topics
- Healthcare Access1▲ 9.9×4 topics
- Infection Control1▲ 30×2 topics
- Radiotherapy1▲ 6.5×8 topics
- Transplantation1▲ 25×2 topics
- Alzheimer's Disease1▲ 8.5×3 topics
- Anatomy1▲ 35×2 topics
- Healthcare Regulation1▲ 25×1 topic
- Medical Devices1▲ 98×1 topic
- Public Policy1▲ 5.1×5 topics
- Smart Library1▲ 59×1 topic
- Surgery1▲ 7.1×4 topics
- Validity and Reliability1▲ 83×2 topics
- Apoptosis1▲ 7.5×3 topics
- Cytokines1▲ 8.1×2 topics
- Kidney Transplantation1▲ 35×2 topics
- Biological Therapy1▲ 37×1 topic
- Disease-Modifying Antirheumatic Drugs1▲ 42×1 topic
- Phosphoethanolamine1▲ 172×1 topic
- Synthetic1▲ 172×1 topic
Which research topics does Santa Casa de Misericórdia de Passos publish most on?
By volume in 2022–2025: Vasculitis and related conditions, Healthcare Regulation, Healthcare during COVID-19 Pandemic and Rheumatoid Arthritis Research and Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Vasculitis and related conditions Pulmonary and Respiratory Medicine 2 works
- 2 Healthcare Regulation Health Information Management 1 works
- 3 Healthcare during COVID-19 Pandemic Information Systems 1 works
- 4 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 5 Biological Research and Disease Studies Molecular Biology 1 works
- 6 Leprosy Research and Treatment Infectious Diseases 1 works
- 7 Health Education and Validation Education 1 works
- 8 T-cell and Retrovirus Studies Immunology 1 works
- 9 Organ Donation and Transplantation Public Health, Environmental and Occupational Health 1 works
- 10 Reproductive System and Pregnancy Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Santa Casa de Misericórdia de Passos's research output changed?
Output in 2018–2022 was 16% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.